Status:
COMPLETED
Monitoring of Cerebral Autoregulation in Pediatric ECMO (ECMOX 1)
Lead Sponsor:
Nantes University Hospital
Collaborating Sponsors:
Istituto Giannina Gaslini
University of Cambridge
Conditions:
Extracorporeal Membrane Oxygenation Complication
Eligibility:
All Genders
1-18 years
Brief Summary
Children supported by Extra-Corporeal Membrane Oxygenation (ECMO) present a high risk of neurological complications and cerebral autoregulation (CA) impairment may be a risk factor. Our first objectiv...
Detailed Description
Patients : All children treated by ECMO in the PICU of the Universitary hospital of Nantes, France and of IRCCS Giannina Gaslini Institute, Genoa, Italy Measurements: A correlation coefficient betwee...
Eligibility Criteria
Inclusion
- Patients 18 years treated by ECMO
Exclusion
- Lack of parental consent
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04282525
Start Date
June 1 2018
End Date
June 1 2019
Last Update
February 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Nantes, Loire-Atlantique, France, 44093